カテゴリー： Market Monitor Global, 世界, 医療/バイオ

組換えヒト卵胞刺激ホルモンの世界市場見通し2023年-2029年

◆英語タイトル：Recombinant Human Follicle-stimulating Hormone Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8630 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：61 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Recombinant Human Follicle-stimulating Hormone Market 調査レポートは次の情報を含め、グローバルにおけるの組換えヒト卵胞刺激ホルモン市場規模と予測を収録しています。・世界の組換えヒト卵胞刺激ホルモン市場：売上、2018年-2023年、2024年-2029年
・世界の組換えヒト卵胞刺激ホルモン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の組換えヒト卵胞刺激ホルモン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「75IU」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

組換えヒト卵胞刺激ホルモンのグローバル主要企業は、Merck、 Ferring、 Livzon、 Gedeon Richter、 GenSci、 Teva、 ChangChun High & New Technology、 ABL、 Scripps Laboratories、 Alphamab Oncology、 Hunan Jingfeng Pharmaceutical、 Qilu Pharmaceutical、 Beijing SL Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、組換えヒト卵胞刺激ホルモンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の組換えヒト卵胞刺激ホルモン市場：タイプ別、2018年-2023年、2024年-2029年
世界の組換えヒト卵胞刺激ホルモン市場：タイプ別市場シェア、2022年
・75IU、150IU、その他

世界の組換えヒト卵胞刺激ホルモン市場：用途別、2018年-2023年、2024年-2029年
世界の組換えヒト卵胞刺激ホルモン市場：用途別市場シェア、2022年
・不妊治療、生殖補助医療

世界の組換えヒト卵胞刺激ホルモン市場：地域・国別、2018年-2023年、2024年-2029年
世界の組換えヒト卵胞刺激ホルモン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における組換えヒト卵胞刺激ホルモンのグローバル売上、2018年-2023年
・主要企業における組換えヒト卵胞刺激ホルモンのグローバル売上シェア、2022年
・主要企業における組換えヒト卵胞刺激ホルモンのグローバル販売量、2018年-2023年
・主要企業における組換えヒト卵胞刺激ホルモンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Merck、 Ferring、 Livzon、 Gedeon Richter、 GenSci、 Teva、 ChangChun High & New Technology、 ABL、 Scripps Laboratories、 Alphamab Oncology、 Hunan Jingfeng Pharmaceutical、 Qilu Pharmaceutical、 Beijing SL Pharmaceutical

*************************************************************

・調査・分析レポートの概要
組換えヒト卵胞刺激ホルモン市場の定義
市場セグメント
世界の組換えヒト卵胞刺激ホルモン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の組換えヒト卵胞刺激ホルモン市場規模
世界の組換えヒト卵胞刺激ホルモン市場規模：2022年 VS 2029年
世界の組換えヒト卵胞刺激ホルモン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの組換えヒト卵胞刺激ホルモンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の組換えヒト卵胞刺激ホルモン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：75IU、150IU、その他
組換えヒト卵胞刺激ホルモンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：不妊治療、生殖補助医療
組換えヒト卵胞刺激ホルモンの用途別グローバル売上・予測

・地域別市場分析
地域別組換えヒト卵胞刺激ホルモン市場規模 2022年と2029年
地域別組換えヒト卵胞刺激ホルモン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Ferring、 Livzon、 Gedeon Richter、 GenSci、 Teva、 ChangChun High & New Technology、 ABL、 Scripps Laboratories、 Alphamab Oncology、 Hunan Jingfeng Pharmaceutical、 Qilu Pharmaceutical、 Beijing SL Pharmaceutical
...

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Follicle-stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Follicle-stimulating Hormone. This report contains market size and forecasts of Recombinant Human Follicle-stimulating Hormone in global, including the following market information:
Global Recombinant Human Follicle-stimulating Hormone Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Recombinant Human Follicle-stimulating Hormone market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
75IU Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Follicle-stimulating Hormone include Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL and Scripps Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Follicle-stimulating Hormone companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Follicle-stimulating Hormone Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Human Follicle-stimulating Hormone Market Segment Percentages, by Type, 2022 (%)
75IU
150IU
Others
Global Recombinant Human Follicle-stimulating Hormone Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Recombinant Human Follicle-stimulating Hormone Market Segment Percentages, by Application, 2022 (%)
Infertility Treatment
Assisted Reproductive Technology
Global Recombinant Human Follicle-stimulating Hormone Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Recombinant Human Follicle-stimulating Hormone Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Follicle-stimulating Hormone revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Recombinant Human Follicle-stimulating Hormone revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Follicle-stimulating Hormone, market overview.
Chapter 2: Global Recombinant Human Follicle-stimulating Hormone market size in revenue.
Chapter 3: Detailed analysis of Recombinant Human Follicle-stimulating Hormone company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Follicle-stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Follicle-stimulating Hormone Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Follicle-stimulating Hormone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Follicle-stimulating Hormone Overall Market Size
2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size: 2022 VS 2029
2.2 Global Recombinant Human Follicle-stimulating Hormone Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Human Follicle-stimulating Hormone Players in Global Market
3.2 Top Global Recombinant Human Follicle-stimulating Hormone Companies Ranked by Revenue
3.3 Global Recombinant Human Follicle-stimulating Hormone Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Human Follicle-stimulating Hormone Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Human Follicle-stimulating Hormone Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Human Follicle-stimulating Hormone Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Recombinant Human Follicle-stimulating Hormone Market Size Markets, 2022 & 2029
4.1.2 75IU
4.1.3 150IU
4.1.4 Others
4.2 By Type – Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
4.2.1 By Type – Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
4.2.2 By Type – Global Recombinant Human Follicle-stimulating Hormone Revenue, 2024-2029
4.2.3 By Type – Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Recombinant Human Follicle-stimulating Hormone Market Size, 2022 & 2029
5.1.2 Infertility Treatment
5.1.3 Assisted Reproductive Technology
5.2 By Application – Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
5.2.1 By Application – Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
5.2.2 By Application – Global Recombinant Human Follicle-stimulating Hormone Revenue, 2024-2029
5.2.3 By Application – Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Recombinant Human Follicle-stimulating Hormone Market Size, 2022 & 2029
6.2 By Region – Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
6.2.1 By Region – Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
6.2.2 By Region – Global Recombinant Human Follicle-stimulating Hormone Revenue, 2024-2029
6.2.3 By Region – Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2029
6.3.2 US Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.3.3 Canada Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.3.4 Mexico Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2029
6.4.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4.3 France Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4.4 U.K. Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4.5 Italy Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4.6 Russia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4.7 Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.4.8 Benelux Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2029
6.5.2 China Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.5.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.5.4 South Korea Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.5.5 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.5.6 India Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2029
6.6.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.6.3 Argentina Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2029
6.7.2 Turkey Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.7.3 Israel Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.7.4 Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
6.7.5 UAE Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2029
7 Recombinant Human Follicle-stimulating Hormone Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Ferring
7.2.1 Ferring Company Summary
7.2.2 Ferring Business Overview
7.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.2.5 Ferring Key News & Latest Developments
7.3 Livzon
7.3.1 Livzon Company Summary
7.3.2 Livzon Business Overview
7.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.3.5 Livzon Key News & Latest Developments
7.4 Gedeon Richter
7.4.1 Gedeon Richter Company Summary
7.4.2 Gedeon Richter Business Overview
7.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.4.5 Gedeon Richter Key News & Latest Developments
7.5 GenSci
7.5.1 GenSci Company Summary
7.5.2 GenSci Business Overview
7.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.5.5 GenSci Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 ChangChun High & New Technology
7.7.1 ChangChun High & New Technology Company Summary
7.7.2 ChangChun High & New Technology Business Overview
7.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.7.5 ChangChun High & New Technology Key News & Latest Developments
7.8 ABL
7.8.1 ABL Company Summary
7.8.2 ABL Business Overview
7.8.3 ABL Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.8.5 ABL Key News & Latest Developments
7.9 Scripps Laboratories
7.9.1 Scripps Laboratories Company Summary
7.9.2 Scripps Laboratories Business Overview
7.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.9.5 Scripps Laboratories Key News & Latest Developments
7.10 Alphamab Oncology
7.10.1 Alphamab Oncology Company Summary
7.10.2 Alphamab Oncology Business Overview
7.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.10.5 Alphamab Oncology Key News & Latest Developments
7.11 Hunan Jingfeng Pharmaceutical
7.11.1 Hunan Jingfeng Pharmaceutical Company Summary
7.11.2 Hunan Jingfeng Pharmaceutical Business Overview
7.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.11.5 Hunan Jingfeng Pharmaceutical Key News & Latest Developments
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Company Summary
7.12.2 Qilu Pharmaceutical Business Overview
7.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.12.5 Qilu Pharmaceutical Key News & Latest Developments
7.13 Beijing SL Pharmaceutical
7.13.1 Beijing SL Pharmaceutical Company Summary
7.13.2 Beijing SL Pharmaceutical Business Overview
7.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.13.5 Beijing SL Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Recombinant Human Follicle-stimulating Hormone Market Opportunities & Trends in Global Market
Table 2. Recombinant Human Follicle-stimulating Hormone Market Drivers in Global Market
Table 3. Recombinant Human Follicle-stimulating Hormone Market Restraints in Global Market
Table 4. Key Players of Recombinant Human Follicle-stimulating Hormone in Global Market
Table 5. Top Recombinant Human Follicle-stimulating Hormone Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Recombinant Human Follicle-stimulating Hormone Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Recombinant Human Follicle-stimulating Hormone Revenue Share by Companies, 2018-2023
Table 8. Global Companies Recombinant Human Follicle-stimulating Hormone Product Type
Table 9. List of Global Tier 1 Recombinant Human Follicle-stimulating Hormone Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Recombinant Human Follicle-stimulating Hormone Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 32. Merck Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Ferring Company Summary
Table 35. Ferring Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 36. Ferring Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 37. Ferring Key News & Latest Developments
Table 38. Livzon Company Summary
Table 39. Livzon Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 40. Livzon Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 41. Livzon Key News & Latest Developments
Table 42. Gedeon Richter Company Summary
Table 43. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 44. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 45. Gedeon Richter Key News & Latest Developments
Table 46. GenSci Company Summary
Table 47. GenSci Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 48. GenSci Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 49. GenSci Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 52. Teva Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Key News & Latest Developments
Table 54. ChangChun High & New Technology Company Summary
Table 55. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 56. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 57. ChangChun High & New Technology Key News & Latest Developments
Table 58. ABL Company Summary
Table 59. ABL Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 60. ABL Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 61. ABL Key News & Latest Developments
Table 62. Scripps Laboratories Company Summary
Table 63. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 64. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 65. Scripps Laboratories Key News & Latest Developments
Table 66. Alphamab Oncology Company Summary
Table 67. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 68. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 69. Alphamab Oncology Key News & Latest Developments
Table 70. Hunan Jingfeng Pharmaceutical Company Summary
Table 71. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 72. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 73. Hunan Jingfeng Pharmaceutical Key News & Latest Developments
Table 74. Qilu Pharmaceutical Company Summary
Table 75. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 76. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 77. Qilu Pharmaceutical Key News & Latest Developments
Table 78. Beijing SL Pharmaceutical Company Summary
Table 79. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Offerings
Table 80. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (US$, Mn) & (2018-2023)
Table 81. Beijing SL Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Recombinant Human Follicle-stimulating Hormone Segment by Type in 2022
Figure 2. Recombinant Human Follicle-stimulating Hormone Segment by Application in 2022
Figure 3. Global Recombinant Human Follicle-stimulating Hormone Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Follicle-stimulating Hormone Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Human Follicle-stimulating Hormone Revenue in 2022
Figure 8. By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 9. By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 10. By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 12. By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 14. By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 15. By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 16. US Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 20. Germany Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 21. France Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 28. China Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 32. India Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 34. Brazil Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2029
Figure 37. Turkey Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Recombinant Human Follicle-stimulating Hormone Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ferring Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Livzon Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GenSci Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ABL Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 組換えヒト卵胞刺激ホルモンの世界市場見通し2023年-2029年(Recombinant Human Follicle-stimulating Hormone Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

組換えヒト卵胞刺激ホルモンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp